Dopa-responsive dystonia revisited: Diagnostic delay, residual signs, and nonmotor signs

Archives of Neurology

Volumn 69, Issue 12, 2012, Pages 1558-1562

  Tadic, Vera ^a   Kasten, Meike ^a   Brüggemann, Norbert ^a   Stiller, Sophie ^a   Hagenah, Johann ^a   Klein, Christine ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARM; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTRACTURE; CONTROLLED STUDY; DELAYED DIAGNOSIS; DEPRESSION; DOPA RESPONSIVE DYSTONIA; DYSTONIA; FEMALE; GENE MUTATION; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I GENE; HUMAN; INFANT; LEG; MALE; MIGRAINE; NECK; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PARKINSONISM; PILOT STUDY; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD;

DELAYED DIAGNOSIS; DYSTONIC DISORDERS; GTP CYCLOHYDROLASE; HUMANS; MEDLINE; MUTATION;

EID: 84871256724     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2012.574     Document Type: Review

References (10)

1. Nygaard TG, Marsden CD, Duvoisin RC. Dopa-responsive dystonia. Adv Neurol. 1988;50:377-384.
2. Segawa M, Hosaka A, Miyagama F, Nomura Y, Imai H. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol. 1976;14:214-233.
3. Ichinose H, Ohye T, Takahashi E, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet. 1994;8(3):236-242. (Pubitemid 24338734)
4. Chaila EC, McCabe DJ, Delanty N, Costello DJ, Murphy RP. Broadening the phenotype of childhood-onset dopa-responsive dystonia. Arch Neurol. 2006;63(8):1185-1188. (Pubitemid 44232330)
5. Nar H, Huber R, Auerbach G, et al. Active site topology and reaction mechanism of GTP cyclohydrolase I. Proc Natl Acad Sci U S A. 1995;92(26):12120-12125. (Pubitemid 26014023)
6. Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR; NMSS Validation Group. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Mov Disord. 2011;26(3):399-406.
7. Leentjens AF, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P. Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Mov Disord. 2011;26(3):407-415.
8. Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord. 2008;23(2):183-189, quiz 313.
9. Lieb K, Frauenknecht S, Brunnhuber S. Intensivkurs Psychiatrie und Psychotherapie [in German]. 6th ed. Munich, Germany: Urban & Fischer; 2008.
10. Van Hove JLK, Steyaert J, Matthijs G, et al. Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency. J Neurol Neurosurg Psychiatry. 2006;77(1):18-23. (Pubitemid 43022684)